Literature DB >> 10799448

Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells.

T Goode1, J O'Connell, W Z Ho, G C O'Sullivan, J K Collins, S D Douglas, F Shanahan.   

Abstract

Substance P (SP) has been implicated in peripheral and mucosal neuroimmunoregulation. However, confusion remains regarding immunocyte expression of the receptor for SP, neurokinin-1 receptor (NK-1R), and whether there is differential NK-1R expression in the mucosal versus the peripheral immune system. In the same assay systems, we examined the expression of NK-1R in human lamina propria mononuclear cells (LPMC), peripheral blood mononuclear cells (PBMC), peripheral blood lymphocytes (PBL), monocytes, and monocyte-derived macrophages (MDM). Using standard reverse transcription (RT)-PCR, mRNA expression of both the long and the short isoforms of the NK-1R was evident in LPMC but not in PBMC, PBL, monocytes, or MDM. However, by using nested RT-PCR NK-1R mRNA expression was detected in PBMC, PBL, monocytes, and MDM. This level of expression was found to represent one NK-1R mRNA transcript in >1,000 cells. In contrast, by using competitive RT-PCR we demonstrate that LPMC express a more biologically significant level of eight NK-1R mRNA transcripts per cell. Flow cytometric detection of NK-1R expression at the protein level was evident in LPMC but not in PBMC. These findings illustrate the extreme sensitivity of nested RT-PCR and the advantages of competitive RT-PCR in comparative studies of receptor expression in different cell populations. This study suggests that, under normal conditions, readily detectable expression of NK-1R in human mononuclear cells occurs at the mucosal level rather than in the peripheral circulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799448      PMCID: PMC95881          DOI: 10.1128/CDLI.7.3.371-376.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  42 in total

1.  Isolation of highly purified human blood monocytes for in vitro HIV-1 infection studies of monocyte/macrophages.

Authors:  N F Hassan; J R Cutilli; S D Douglas
Journal:  J Immunol Methods       Date:  1990-07-03       Impact factor: 2.303

2.  Substance P increases lymphocyte traffic and lymph flow through peripheral lymph nodes of sheep.

Authors:  T C Moore; J L Lami; C H Spruck
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

3.  Biochemical characterization of two different forms of the substance P receptor in rat submaxillary gland.

Authors:  R Kage; S E Leeman; N D Boyd
Journal:  J Neurochem       Date:  1993-01       Impact factor: 5.372

4.  Substance P and substance K receptor binding sites in the human gastrointestinal tract: localization by autoradiography.

Authors:  T S Gates; R P Zimmerman; C R Mantyh; S R Vigna; J E Maggio; M L Welton; E P Passaro; P W Mantyh
Journal:  Peptides       Date:  1988 Nov-Dec       Impact factor: 3.750

5.  Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization.

Authors:  T Goode; J O'Connell; C Sternini; P Anton; H Wong; G C O'Sullivan; J K Collins; F Shanahan
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

6.  Human lymphocytes lack substance P receptors.

Authors:  A I Roberts; J Taunk; E C Ebert
Journal:  Cell Immunol       Date:  1992-05       Impact factor: 4.868

Review 7.  Substance P: a late-acting B lymphocyte differentiation cofactor.

Authors:  K L Bost; D W Pascual
Journal:  Am J Physiol       Date:  1992-03

8.  Effect of neuropeptides on production of inflammatory cytokines by human monocytes.

Authors:  M Lotz; J H Vaughan; D A Carson
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

9.  Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.

Authors:  T M Fong; S A Anderson; H Yu; R R Huang; C D Strader
Journal:  Mol Pharmacol       Date:  1992-01       Impact factor: 4.436

10.  Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanism.

Authors:  A Kavelaars; F Jeurissen; J von Frijtag Drabbe Künzel; J Herman van Roijen; G T Rijkers; C J Heijnen
Journal:  J Neuroimmunol       Date:  1993-01       Impact factor: 3.478

View more
  11 in total

Review 1.  Without nerves, immunology remains incomplete -in vivo veritas.

Authors:  Andrew J Shepherd; James E G Downing; Jaleel A Miyan
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

Review 2.  Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Authors:  Steven D Douglas; Susan E Leeman
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

3.  Anatomical evidence for enteric neuroimmune interactions in Peyer's patches.

Authors:  Lucy Vulchanova; Melissa A Casey; Gwen W Crabb; William R Kennedy; David R Brown
Journal:  J Neuroimmunol       Date:  2007-03-23       Impact factor: 3.478

4.  Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.

Authors:  J-P Lai; W Z Ho; L E Kilpatrick; X Wang; F Tuluc; H M Korchak; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-04       Impact factor: 11.205

5.  TGF-beta regulates T-cell neurokinin-1 receptor internalization and function.

Authors:  Martin Beinborn; Arthur Blum; Long Hang; Tommy Setiawan; Jonathan C Schroeder; Korynn Stoyanoff; John Leung; Joel V Weinstock
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

6.  Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes.

Authors:  M Gallicchio; E Benetti; A C Rosa; R Fantozzi
Journal:  Br J Pharmacol       Date:  2009-01-16       Impact factor: 8.739

7.  Substance P induces rapid and transient membrane blebbing in U373MG cells in a p21-activated kinase-dependent manner.

Authors:  John Meshki; Steven D Douglas; Mingyue Hu; Susan E Leeman; Florin Tuluc
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

Review 8.  Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation.

Authors:  B N Lambrecht
Journal:  Respir Res       Date:  2001-04-19

Review 9.  COVID-19 Diagnostic Strategies. Part I: Nucleic Acid-Based Technologies.

Authors:  Tina Shaffaf; Ebrahim Ghafar-Zadeh
Journal:  Bioengineering (Basel)       Date:  2021-04-17

Review 10.  The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease.

Authors:  Martina Di Giovangiulio; Simon Verheijden; Goele Bosmans; Nathalie Stakenborg; Guy E Boeckxstaens; Gianluca Matteoli
Journal:  Front Immunol       Date:  2015-11-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.